Literature DB >> 18984872

Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells.

Véronique Roelants1, Daniel Labar, Carole de Meester, Xavier Havaux, Antonio Tabilio, Sanjiv S Gambhir, Mauro Di Ianni, Anne Bol, Luc Bertrand, Jean-Louis Vanoverschelde.   

Abstract

UNLABELLED: Mesenchymal stem cells (MSCs) are a promising cell line for the treatment of ischemic heart disease. To evaluate the success of their transplantation into living animals, noninvasive imaging techniques that are able to track the distribution and fate of those cells would be useful. The aim of this study was to investigate the feasibility of infecting rat MSCs with adenoviruses and retroviruses carrying the herpes simplex virus type 1 thymidine kinase (HSV1-tk) gene; to compare the level of transgene expression induced by the 2 viral vectors; to evaluate the effects of viral transduction on cell phenotype, viability, proliferation rates, and differentiation capabilities; and to test the possibility of noninvasively imaging transduced MSCs using 9-(4-18F-fluoro-3-[hydroxymethyl]butyl)guanine (18F-FHBG) and small-animal PET after their transplantation into living rats.
METHODS: We infected rat bone marrow MSCs with adenoviruses carrying the HSV1 mutant tk (Ad-HSV1-sr39tk) PET reporter gene (PRG) or with a retroviral construct expressing the wild-type HSV1-tk PRG. The efficacy and intensity of HSV1-sr39tk and HSV1-tk gene expression were determined by a direct comparison of [8-3H]-penciclovir ([8-3H]-PCV) cell uptake in both infected MSC populations and noninfected control MSCs. Small-animal PET studies were performed on living rats after an intramuscular injection of infected MSCs. The MSCs either have been incubated in advance with 18F-FHBG or they were administered and 18F-FHBG was thereafter intravenously administered [corrected]
RESULTS: Both adenoviral and retroviral vectors can be used to introduce the tk PRG in MSCs. Neither adenovirus nor retrovirus infections significantly modify MSC phenotype, viability, proliferation, and differentiation capabilities. No significant 3H-PCV uptake was observed in noninfected MSCs. By contrast, after both adenoviral and retroviral infections, the infected MSC populations exhibited a similar, significantly higher, 3H-PCV accumulation. Small-animal PET images showed intense activity within the transplanted regions irrespective of the infected MSC population used.
CONCLUSION: Our results demonstrate the feasibility of infecting MSCs with adenoviruses and retroviruses expressing the HSV1-tk PRG and suggest that infected MSCs can be noninvasively imaged with 18F-FHBG and small-animal PET after their transplantation into living animals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984872     DOI: 10.2967/jnumed.108.052175

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

1.  Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo.

Authors:  Franz Josef Gildehaus; Florian Haasters; Inga Drosse; Erika Wagner; Christian Zach; Wolf Mutschler; Paul Cumming; Peter Bartenstein; Matthias Schieker
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

Review 2.  PET molecular imaging in stem cell therapy for neurological diseases.

Authors:  Jiachuan Wang; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-23       Impact factor: 9.236

3.  From hepatocytes to stem and progenitor cells for liver regenerative medicine: advances and clinical perspectives.

Authors:  E M Sokal
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

Review 4.  Mesenchymal stem cells engineered for cancer therapy.

Authors:  Khalid Shah
Journal:  Adv Drug Deliv Rev       Date:  2011-06-29       Impact factor: 15.470

Review 5.  Intra-Arterial Delivery of Cell Therapies for Stroke.

Authors:  Raphael Guzman; Miroslaw Janowski; Piotr Walczak
Journal:  Stroke       Date:  2018-04-18       Impact factor: 7.914

6.  Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells.

Authors:  W Chai; X Yin; L Ren; M Cai; T Long; M Zhou; Y Tang; N Yang; S Hu
Journal:  Clin Transl Oncol       Date:  2015-06-27       Impact factor: 3.405

Review 7.  Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  Adv Drug Deliv Rev       Date:  2010-09-07       Impact factor: 15.470

8.  Treatment of Hemophilia A in Utero and Postnatally using Sheep as a Model for Cell and Gene Delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-25

Review 9.  Biodistribution studies for cell therapy products: Current status and issues.

Authors:  Yoshiteru Kamiyama; Yoichi Naritomi; Yuu Moriya; Syunsuke Yamamoto; Tsukasa Kitahashi; Toshihiko Maekawa; Masahiro Yahata; Takeshi Hanada; Asako Uchiyama; Akari Noumaru; Yoshiyuki Koga; Tomoaki Higuchi; Masahiko Ito; Hiroyuki Komatsu; Sosuke Miyoshi; Sadaaki Kimura; Nobuhiro Umeda; Eriko Fujita; Naoko Tanaka; Taku Sugita; Satoru Takayama; Akihiko Kurogi; Satoshi Yasuda; Yoji Sato
Journal:  Regen Ther       Date:  2021-07-12       Impact factor: 3.419

10.  An in vitro and in vivo evaluation of a reporter gene/probe system hERL/(18)F-FES.

Authors:  Chunxia Qin; Xiaoli Lan; Jiang He; Xiaotian Xia; Yueli Tian; Zhijun Pei; Hui Yuan; Yongxue Zhang
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.